Soluble Adhesion Molecules and Endothelial Cell Damage in HIV Infected Patients

Summary

Endothelial damage is present in HIV infection but our understanding of markers and mechanisms is incomplete. We found increased levels of markers of endothelial cell damage such as von Willebrand factor (vWf), soluble thrombomodulin (sTM) and adhesion molecule E- selectin in 90 subjects seropositive for HIV relative to healthy controls. sTM was strongly raised in those patients with the lowest CD4+ cell count (p <0.001), but levels of vWf increased at each incremental fall in CD4+ cell count and the two indices correlated significantly (r = -0.485, p <0.001). vWf correlated strongly with levels of the inflammatory cytokines tumor necrosis factor (TNF-α) and alpha interferon (IFN-α) but sTM correlated only weakly with IFN-α. We suggest that increased vWf is largely the result of inflammatory stimulus of the endothelium but that sTM is found only in those patients with more severe disease, and so truely represents endothelial damage.

• References

• 1 Tabib A, Greeland T, Mercier I, Loire R, Mornex JF. Coronary lesions in young HIV-positive patients at necropsy. Lancet 1992; 340: 730
• 2 Capron L, Kim YU, Laurin C, Bruneval P, Fiessinger JN. Atheroembolism in HIV-positive individuals. Lancet 1992; 340: 1039-1040
• 3 Constans J, Marchand JM, Conri C, Peuchant E, Seigneur M, Rispal P, Lasseur C, Pellegrin JL, Leng B. Asymptomatic atherosclerosis in HIVpositive patients: a case-controlled ultrasound study. Ann Med 1995; 27: 683-685
• 4 Cotte JR, Lackner R, Xenig P, Pillary G. Deep venous thrombosis in patients with AIDS. NY State J Med 1990; 20: 159-161
• 5 Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, Gastatut JA. Endothelial cell dysfunction in HIV infection. J AIDS 1992; 05: 127-131
• 6 Constans J, Pellegrin JL, Peuchant E, Dumon MF, Pellegrin I, Sergeant C, Simonoff M, Brossard G, Barbeau P, Fleury H, Clerc M, Leng B, Conri C. Plasma lipids in HIV-infected patients: a prospective study in 95 patients. Eur J Clin Invest 1994; 24: 416-420
• 7 Constans J, Pellegrin JL, Peuchant E, Dumon MF, Simonoff M, Clerc M, Leng B, Conri C. High plasma lipoprotein (a) in HIV-positive patients. Lancet 1993; 341: 1099-1100
• 8 Constans J, Peuchant E, Pellegrin JL, Sergeant C, Hamon C, Dubourg L, Thomas MJ, Simonoff M, Pellegrin I, Brossard G, Barbeau P, Fleury H, Clerc M, Leng B, Conri C. Fatty acids and plasma antioxidants in HIV positive patients: correlation with nutritional and immunological status. Clin Biochem 1995; 28: 421-426
• 9 Cenacchi G, Re MC, Pasquinelli G, Furlini G, Apkarian RP, La PlacaM, Martinelli GN. Human immunodeficiency virus type-1 (HIV-1) infection of endothelial cells in vitro: a virological, ultrastructural and immuno-cytochemical approach. J Submicrosc Cytol Pathol 1992; 24: 155-161
• 10 Wiley CA, Schrier D, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83: 7089-7093
• 11 Pomerantz RJ, Kuritzkes DR, de la, Monte SM, Rota TR, Baker AS, Albert D, Bor DH, Feldman EL, Schooley TR, Hirsch MS. Infection of the retina by human immunodeficiency virus type 1. N Engl J Med 1987; 317: 1643-1647
• 12 Lee S, Harris C, Hirschfeld P, Dickson DW. Cytomembranous inclusions in the brain of a patient with the acquired immunodeficiency syndrome. Acta Neuropathol 1988; 76: 101-106
• 13 Teitel J, Shore A, Read SE, Shiavone A. Immune function of vascular endothelial cells is impaired by HIV. J Infect Dis 1989; 160: 551-552
• 14 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
• 15 Crossman DC, Tuddenham EDG. Procoagulant functions of endothelium. In: The endothelium. An introduction to current research. Warren JB. eds. J. Wiley & Sons Inc; New York, NY: 1990. pp 119-128
• 16 Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost A, Boisseau MR. Plasma thrombomodulin: new approach of endothelium damage. Int Angiol 1993; 12: 355-359
• 17 Seigneur M, Dufourcq P, Conri C, Constans J, Mercié P, Pruvost A, Amiral J, Midy D, Baste JC, Boisseau MR. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993; 71: 423-431
• 18 Blann AD, McCollum CN. von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vase Surg 1994; 08: 10-15
• 19 Blann AD, Amiral J, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in ischemic heart disease. Br J Haematol 1996; 95: 263-265
• 20 Newman W, Dawson BeallL, Carson CW, Hunder GG, Graben N, Rand-hawa ZI, Gopal TV, Wiener-Kronish JW, Matthay MA. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993; 150: 644-654
• 21 Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Com 1992; 187: 584-589
• 22 Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994; 72: 151-154
• 23 Hackman A, Yasunori A, Insull W, Pownall H, Smith L, Dun K, Gotto AM, Ballantyne CM. Levels of soluble cell adhesion molecules in patients with dyslipemia. Circulation 1996; 93: 1334-1338
• 24 Tannenbaum SH, Gralnick HR. Gamma interferon modulates von Willebrand factor release by cultured human endothelial cells. Blood 1990; 75: 2177-2184
• 25 Paleolog EM, Carew MA, Pearson JD. Effects of tumor necrosis factor and interleukin-1 on von Willebrand factor secretion from human vascular endothelial cells. Int J Radiat Biol 1991; 60: 279-285
• 26 Hennig B, Chung BH, Watkins BA, Alvarado A. Disruption of endothelial barrier function by lipolytic remnants of triglycerides-rich lipoproteins. Atherosclerosis 1992; 95: 235-247
• 27 Witzum JL, Steinberg D. Role of oxidised low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792
• 28 Blann AD, McCollum CN, Steiner M, Jayson MIV. Circulating adhesion molecules in inflammatory and atherosclerotic vascular disease. Immunol Today 1995; 16: 251-252
• 29 Lebon P, Daffos F, Checoury A, Grangeot-Keros L, Forestier F, Toublanc JE. Presence of an acid-labile alpha-interferon in sera from foetuses and children with congenital rubella. J Clin Microbiol 1985; 21: 775-778
• 30 Schved JF, Gris JC, Arnaud A, Martinez P, Sanchez N, Wautier JL, Sarlat C. von Willebrand factor antigen, tissue type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1 related clinical disease: independent prognostic relevance of tissue type plasminogen activator. J Lab Clin Med 1992; 129: 411-419
• 31 Beilke MA. Vascular endothelium in immunology and infectious disease. Rev Infect Dis 1989; 11: 273-283
• 32 Hober D, Haque A, Wattre P, Beaucaire G, Mouton Y, Capron A. Production of tumor necrosis factor and interleukin-1 in patients with AIDS Enhanced level of TNF is related to a higher cytotoxic activity. Clin Exp Immunol 1989; 78: 329
• 33 Zangerle R, Fuchs D, Sarcletti M, Gallati H, Reibnegger G, Wachter H, Dierich MP, Möst J. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection. Clin Immunol and Immunopathol 1994; 72: 328-334
• 34 Constans J, Pellegrin I, Pellegrin JL, Peuchant E, Dumont MF, Sergeant C, Simonoff M, Barbeau P, Brossard G, Fleury H, Clerc M, Leng B, Conri C. Interferon alpha and the wasting syndrome in HIV infection. Clin Infect Dis 1995; 20: 1069-1070